Marel Q1 2015 result Strong sales and operational

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Marel Q1 2015 result Strong sales and operational improvement
  •  Revenue for Q1 2015 totaled 209.3m [Q1 2014: 154.8m].
  •  Adjusted EBITDA* for Q1 2015 was 36.9m or 17.6% of revenue [Q1 2014: 11.6m]. EBITDA was 29.4m or 14.0% of revenue [Q1 2014: 8.1m].
  •  Adjusted operating profit* (adj.EBIT) for Q1 2015 was 23.8m or 11.4% of revenue [Q1 2014: 4.6m]. EBIT was 16.2m or 7.8% of revenue [Q1 2014: 1.0m]. 
  •  Net result for Q1 2015 was 12.6m [Q1 2014: Loss of 1.9m]. Earnings per share was 1.73 euro cents compared with a loss of 0.25 euro cents in Q1 2014.
  •  Cash flow from operating activities before interest and tax was 39.5m [Q1 2014: 19.4m]. Net interest bearing debt was 161.7m [Q1 2015: 208.4m].
  •  The order book was at 178.0m at the end of the quarter compared with 174.9m at the end of Q4 2014.

The year 2015 starts well for Marel. The company showed significant increase in operational and net profit from previous quarters fuelled by record revenues and order intake as well as operational improvements derived from a simplified and streamlined organization. The strong financial position with net debt/EBITDA at 1.48 enables Marel to further stimulate growth and strengthen its competitive position. There is a general tailwind in Marel’s main markets in addition to favorable conditions in the financial markets.   

Two subsequent events have taken place between the end of Q1 and the publishing date of the Q1 results;

• The sale of the High Speed Slicing operations in Norwich, U.K., which was agreed in February 2015, was closed in April with a slightly positive P/L effect and total estimated cash proceeds of 9.5 million.  

• The real estate in Oss, Netherlands, was sold in April delivering cash proceeds of 2.4 million. The Oss operation was previously transferred to the multi-industry center in Boxmeer to better utilize manpower and investments and as well, allow the company to be better equipped to deal with fluctuations in demand among various product groups and industries.

From the beginning of the refocusing program until the end of Q1, taking into account the proceeds from the above mentioned subsequent events, the total cash-out cost of the refocusing program stands at 12 million with an 27 million in P/L effect.

Management guidance for 2015 is organic revenue growth, with a solid increase in operational and net profit. Full focus remains on strengthening the market approach and operational improvement with the aim to reach EBIT of over 100 million in 2017.

Arni Oddur Thordarson, CEO:  “We are pleased with the good results in the beginning of 2015.  With a focused market approach and strong commercial product portfolio we managed to utilize the tailwind in Marel´s main markets resulting in record order intake, revenues and significantly improved operational results.  Our sales growth is well balanced between Greenfield projects, extension and modernization projects and growth in our maintenance business.  We have invested well in innovation and we have been introducing steady flow of new and exciting solutions to enable poultry, fish and meat processors to further optimize yield and throughput as well as minimizing waste and reducing usage of water and energy, making the value chain more sustainable. 

All industries are showing improved operational results. I want to express my thanks to our employees for their efforts and commitment.  At the same time we are refocusing and streamlining the operation we have managed to strengthen our partnership with existing customers and attract new customers. The goal is always the same, to deliver increased value to customers and shareholders.”

Authorization to purchase own shares

Board of Directors of Marel has granted management an authorization to purchase up to 25 million own shares on the behalf of the company in one or more transactions in the period that is remaining of the calendar year 2015. The shares are to be used as payment for potential future acquisitions that needs full approval of the Board of Directors.     

Simpler, Smarter, Faster refocusing program The Simpler, Smarter, Faster two year refocusing program is on track. The program focuses on simplifying the market approach to better serve the customer needs and to streamline operations to increase quality and efficiency in the company while lowering the recurring cost base. There is special focus on innovation and manufacturing optimization. The innovation and manufacturing optimization is well on track. In Q1 Marel announced the streamlining of its operations in Singapore, Denmark, the U.S. and the U.K. as well as the divestment of a non-core business in Spain. The sale of Stork Inter Ibérica in Spain was concluded during the quarter. The closing of the sale of the High Speed Slicing operations in the U.K. took place in April, though the deal was signed during Q1. From the beginning of the refocusing program until the end of Q1, taking into account the proceeds from subsequent events, the total cash-out cost of the refocusing program is at 12 million with 27 million in P/L effect for the same period. Total estimated cash-out costs related to refocusing actions is 25 million over the whole refocusing period while the total P/L effect cannot be fully estimated at this time. Refocusing actions taken during Q1 2015:

  •  Ceasing of manufacturing of freezers in Singapore. Marel is entering into partnerships with Heinen and VDL to continue to provide freezing solutions to its customers. The aim is to support Marel’s full line offerings in fish, meat and poultry processing.
  •  Streamlining of U.S. operations. The manufacturing operation in Des Moines will merge with an existing facility in Gainesville. At the same time, a new innovation center will be established in Des Moines. The transition process will be completed before year-end 2015.
  •  Streamlining of operations in Denmark. All activities in Bornholm, Denmark will be transferred to existing facilities in Aarhus and Nitra. The transition process will be completed before year-end 2015.
  •  Divestment of non-core palletizing business in Spain. Stork Inter Ibérica was sold to a private investment group.
  •  Streamlining of U.K. operations. High Speed Slicing operations in Norwich, U.K. were sold  to the Middleby Corporation. Marel will retain the frozen portioning and robotics families, which remain of strategic importance.
  • The discontinued operations mentioned above in Singapore, Spain and the U.K. represented close to 30 million in revenues in 2014 with low gross margins and negative EBIT. Revenues in Q1 from discontinued operations were 6 million and the order book of discontinued operations was 4 million at the end of Q1.

Outlook Management guidance for 2015 is organic revenue growth, with a solid increase in operational and net profit. Full focus remains on strengthening the market approach and operational improvement with the aim to reach EBIT of over 100 million in 2017. In the mid- and long-term, the company believes its innovative products and global presence in all segments will secure good growth and increased profitability. The long-term outlook in the industry remains favorable and the estimated annual market growth for providing advanced solutions and equipment for meat, poultry and fish processing is 4-6%. Marel’s goal is to continue to grow faster than the market, based on its innovative customer solutions and extensive sales and service network. Results may vary from quarter to quarter due to general economic developments, fluctuations in orders received, and deliveries of larger systems.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring CRH Stock Performance Over Five Years and Beyond

Updated Category News Views 152

Understanding CRH's Impressive Growth CRH has displayed a remarkable performance in the stock market over the last five years, outshining many of its competitors with a 10.67% annualized return. This impressive growth translates to an average annual return of 23.49% for investors. Currently, CRH boasts a market capitalization of approximately $73.09 billion, making it a...

Continue Reading
Coordinated Care's Health Tour Expands Access Across WA

Updated Category News Views 78

A Grassroots Push for Health Equity Coordinated Care, a subsidiary of Centene Corporation, is hitting the road in Washington state. This isn't about just another healthcare campaign—you’ve got two vans, 'SeeMore' and 'Flossy', bringing essential vision and dental screenings right up to the folks who need them most. Taking Healthcare Directly to Communities Let's be...

Continue Reading
Italy's Antitrust Agency Investigates Snam-Edison Deal

Updated Category News Views 229

Investigation into the Snam and Edison Gas Storage Deal Italy's antitrust agency has recently initiated an investigation concerning the transaction between Snam and Edison involving Edison's gas storage unit. This move reflects the agency's commitment to maintaining healthy competition within the energy sector. Concerns Over Market Competition The Antitrust Authority,...

Continue Reading
Truist Financial Corporation's Quarterly Performance Insights

Updated Category News Views 240

Truist Financial's Results and Earnings Overview Truist Financial Corporation (TFC) announced its latest quarterly results, showcasing a robust financial performance that illustrates the company’s strategic focus on growth and stability. This release reflects the commitment of Truist to enhance the lives of its clients and communities by providing comprehensive...

Continue Reading
Investigation Into Possible Securities Fraud at UnitedHealth Group

Updated Category News Views 350

UnitedHealth Group Under Scrutiny for Securities Claims Ademi & Fruchter LLP has launched an investigation into potential securities fraud claims against UnitedHealth Group Incorporated (NYSE: UNH). This inquiry arises following inaccurate statements made by the company regarding its operational performance and future outlook. Investors and analysts alike express serious...

Continue Reading